Skip to content

Letter to Dr. Fauci to Support HIV and Aging Research

  • Chad Cipiti
The many complications and comorbidities faced by the aging population of HIV positive people in the United States constitute a rapidly growing medical crisis that has been woefully neglected by U.S. research efforts.
Read more

Letter to David Kessler, US FDA

  • Dorrit Walsh
Dear Commissioner Kessler: We're writing with reference to FDA’s plans to regulate the development of a new class of anti- HIV therapies known as “protease inhibitors,” and with specific reference to possible regulatory decisions regarding Hoffmann-LaRoche, Inc.’s Ro 31-8959 (“saquinavir”).
Read more
Back To Top